Xiaojing Zhu
-
- HER2/EGFR in Cancer Research 2
-
- Nutritional Studies and Diet 2
-
- Kidney Stones and Urolithiasis Treatments 2
- Ferroptosis and cancer prognosis 2
-
- Economic and Environmental Valuation 1
-
- Neonatal and fetal brain pathology 1
-
- Gastroesophageal reflux and treatments 1
-
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Shizhong ZhengDesong KongB. Larry LiXiaodong ZhuYangfan LiXiang SunYin LuSasha Mazzarello
- Journals
- Chemosphere (1 paper)BMC Public Health (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaojing Zhu
17 papers receiving 276 citations
Peers
Comparison fields: 5 of 90
- Hepatology 32
- Pharmacology 26
- Cancer Research 39
- Oncology 66
- Complementary and alternative medicine 18
Countries citing papers authored by Xiaojing Zhu
This map shows the geographic impact of Xiaojing Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Zhu more than expected).
Fields of papers citing papers by Xiaojing Zhu
This network shows the impact of papers produced by Xiaojing Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Zhu. The network helps show where Xiaojing Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaojing Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 3 | |
| 6 | Influence of anti-tuberculosis drugs plus cycloserine on sputum negative conversion rate, adverse reactions and inflammatory factors in multi-drug resistant tuberculosis. | 2021 | 3 |
| 7 | 2020 | 0 | |
| 8 | 2019 | 7 | |
| 9 | 2019 | 5 | |
| 10 | 2019 | 3 | |
| 11 | 2019 | 18 | |
| 12 | 2017 | 3 | |
| 13 | 2017 | 8 | |
| 14 | 2016 | 68 | |
| 15 | HER2 status in molecular apocrine breast cancer: associations with clinical, pathological, and molecular features. | 2015 | 10 |
| 16 | 2014 | 43 | |
| 17 | 2013 | 36 | |
| 18 | 2012 | 50 | |
| 19 | 2009 | 15 |
About Xiaojing Zhu
Xiaojing Zhu is a scholar working on Aging, Obstetrics and Gynecology and Modeling and Simulation, having authored 19 papers that have together received 278 indexed citations. Recurring topics across this work include Nutritional Studies and Diet (2 papers), Kidney Stones and Urolithiasis Treatments (2 papers), Ferroptosis and cancer prognosis (2 papers), HER2/EGFR in Cancer Research (2 papers), Economic and Environmental Valuation (1 paper), Neonatal and fetal brain pathology (1 paper), Gastroesophageal reflux and treatments (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Hepatology (32 citations), Pharmacology (26 citations) and Cancer Research (39 citations). Xiaojing Zhu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shizhong Zheng, Desong Kong, B. Larry Li, Xiaodong Zhu, Yangfan Li, Xiang Sun, Yin Lu, Sasha Mazzarello, John Hilton and Feng Zhang. Their work appears in journals such as Chemosphere, BMC Public Health and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.